Oxford Cannabinoid Technologies Holdings Plc (0CB.F)

0,0010 0,0000 (0,00%) Börsenschluss: 09:59AM CEST

Oxford Cannabinoid Technologies Holdings Plc

Prama House
267 Banbury Road
Oxford OX2 7HT
United Kingdom
44 20 3034 2820
https://www.oxcantech.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 7

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Ms. Clarissa Ann Sowemimo-Coker	CEO & Executive Director	252,01k	N/A	1980
Mr. Indraneil Mahapatra	Co-Founder & Non-Executive Director	29,21k	N/A	1980
Mr. Paul William Smalley	Finance Director & Executive Director	181,3k	N/A	1973
Dr. Valentino Parravicini	Chief Scientific Officer	N/A	N/A	1969
Mr. Robin Bennett	General Counsel & Company Secretary	N/A	N/A	N/A
Dr. Timothy Henry Corn FFPM, M.Sc.	Executive Director & Chief Medical Officer	N/A	N/A	1951

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase – I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Corporate Governance

Oxford Cannabinoid Technologies Holdings Plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.